Drug Trial Radar · NCT07540910
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults
Last checked: Nov 20, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
98
Planned (sponsor's estimate)
Start
Apr 1, 2026
Primary completion
Nov 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- Enanta Pharmaceuticals, IncIndustry
- Sponsor type
- Industry
- First posted
- Apr 21, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is a randomized, double-blind, sponsor-open, placebo-controlled study. It will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered single and multiple doses of EDP-978 in healthy adult subjects.
Conditions
- Chronic Inducible Urticaria
- Chronic Spontaneous Urticaria
Interventions
EDP-978Drug
Oral administration
PlaceboDrug
Placebo to match EDP-978, oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety measured by adverse eventsTime frame: Up to 8 Days in SAD Cohorts
- Safety measured by adverse eventsTime frame: Up to 28 Days in MAD Cohorts
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ICON Early Phase
San Antonio, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.